Dermatology
| Paediatric dermatology
Dermatology
Paediatric dermatology
Dupilumab treatment provides long-term improvement in sleep loss and disease control over 1 years in pediatric patients with moderate-to-severe atopic dermatitis
book_2
Source:
EADV 2024 - Poster session
calendar_today
Published on Medfyle:
October 2024
In this medfyle
Many of the most bothersome symptoms of AD can wax and wane, so consistency of response is important, especially in children, who have a high burden of disease. New data from the LIBERTY AD PED OLE explore long-term improvements over 1 year.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
©2024 Infomedica-Medfyle. All rights reserved.
Source: Dupilumab treatment provides long-term improvement in sleep loss and disease control over 1 years in pediatric patients with moderate-to-severe atopic dermatitis. Siegfried EC, et al. Presented at EADV 2024; #P0729; Abstract #6903.
The information and data provided is for information purposes only. The author(s) of the original original presentation had no involvement in the creation of this content.
